Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma

Publisher Website

31 August 2004

journal article
review article
Published by Elsevier in Lung Cancer

Vol. 45, S125-S127
https://doi.org/10.1016/j.lungcan.2004.04.022

Abstract

No abstract available

Keywords

This publication has 6 references indexed in Scilit:

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
The Journal of Pathology, 2001
Malignant pleural mesothelioma
Current Treatment Options in Oncology, 2000
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer
British Journal of Cancer, 2000
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
British Journal of Cancer, 1999
Chemotherapy in malignant pleural mesothelioma. A review.
Journal of Clinical Oncology, 1996
EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR (PDGF) AND PDGF RECEPTORS IN HUMAN MALIGNANT MESOTHELIOMAIN VITRO ANDIN VIVO
The Journal of Pathology, 1996